Kezar Life Sciences, Inc. (KZR) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which ...
This page features the latest news about the Kezar Life stock. H.C. Wainwright maintains Neutral rating on Kezar shares amid acquisition bid H.C. Wainwright has maintained its Neutral stance on ...
A video circulating on social media showing two people, on the brink of Niagara Falls beyond public safety barriers taking photos is drawing condemnation. “Look at those crazy people,” said a man ...
Kezar Life Sciences, Inc. (“Kezar” or the “Company”) (Nasdaq: KZR), a clinical-stage biotechnology company developing a novel small molecule to treat unmet needs in immune-mediated ...
SOUTH SAN FRANCISCO, Calif., October 10, 2024--(BUSINESS WIRE)--Kezar Life Sciences, Inc. ("Kezar" or the "Company") (Nasdaq: KZR), a clinical-stage biotechnology ...
Kezar Life Sciences, Inc. (“Kezar” or the “Company”) (Nasdaq: KZR), a clinical-stage biotechnology company developing a novel small molecule to treat unmet ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (“Kezar” or the “Company”) (Nasdaq: KZR), a clinical-stage biotechnology company developing a novel small molecule to treat ...
USA-based Kezar Life Sciences (Nasdaq: KZR) announced this week that it was pausing its Phase ... It’s part of the key information for keeping me informed ...